| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/18/2004 | EP1189924B1 Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 08/18/2004 | EP1187814B1 5-phenyl-pyrimidine derivatives |
| 08/18/2004 | EP1178833B1 Topical compositions for prostaglandin e 1 delivery |
| 08/18/2004 | EP1140119B1 Use OF LOW MOLECULAR WEIGHT HEPARIN for the prevention and/or treatment of motoneuronal diseases |
| 08/18/2004 | EP1117676B1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 08/18/2004 | EP1030857B1 Adenosine a1 receptor agonists |
| 08/18/2004 | EP1030856B1 Adenosine a1 receptor agonists |
| 08/18/2004 | EP0984928A4 Aromatic and heterocyclic nitrato derivatives |
| 08/18/2004 | EP0944599B1 Triarylethanes useful as pde iv inhibitors |
| 08/18/2004 | EP0744950B1 Agent for prophylaxis and treatment of thromboxane a2 mediated diseases |
| 08/18/2004 | EP0663014B1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 08/18/2004 | CN1522303A Method for detecting a risk of hypertension and uses thereof |
| 08/18/2004 | CN1522258A Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines |
| 08/18/2004 | CN1522257A Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 08/18/2004 | CN1522256A Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine |
| 08/18/2004 | CN1522253A Novel heterocyclic derivatives and medicinal use thereof |
| 08/18/2004 | CN1522250A Cyclic diamine compound having five-membered cyclic group |
| 08/18/2004 | CN1522248A Novel butadiene derivatives, process for preparation of the same and intermediates for the synthesis thereof |
| 08/18/2004 | CN1522246A Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (MTP) and/or apolipoprotein b (APO B) secretion |
| 08/18/2004 | CN1522244A Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 08/18/2004 | CN1522151A Modified fvii in treatment of ards |
| 08/18/2004 | CN1522149A Promoting whole body health |
| 08/18/2004 | CN1522143A Coenzyme q and eicosapentaenoic acid (epa) |
| 08/18/2004 | CN1522142A Potassium channel opener |
| 08/18/2004 | CN1520882A Trombolysis agent KGD - prourokinase chimaera, preparing process and application thereof |
| 08/18/2004 | CN1520862A Prepared traditional Chinese medicine for apoplexy and obstruction of qi in the chest |
| 08/18/2004 | CN1520859A Cerebrovascular and cardiovascular disease treating injection containing red-rooted salvia and safflower |
| 08/18/2004 | CN1520853A Sonchifolia Hance solid medical preparation and its manufacture process |
| 08/18/2004 | CN1520852A Sonchifolia Hance oral liquid and its manufacture process |
| 08/18/2004 | CN1520835A Liver cirrhosis and arteriosclerosis pharmaceutical composition |
| 08/18/2004 | CN1520832A Haw leaf injection for treating cardiovascular disease |
| 08/18/2004 | CN1520829A Earthworm freeze dried powder injection and preparation method |
| 08/18/2004 | CN1520826A Medicinal composition for improving sea-buckthorn flavone bioavailability |
| 08/18/2004 | CN1520817A Nimodipine slow release capsule and its preparation method |
| 08/18/2004 | CN1520814A Ginkgo leaf extract and its preparation |
| 08/18/2004 | CN1520812A Troxerutin injection and its preparation method |
| 08/18/2004 | CN1520805A Ubiquinone containing composition |
| 08/18/2004 | CN1520776A Silicon oil paper towel for hemorrhoid prevention and cure |
| 08/18/2004 | CN1162445C Jackfruit cycloalkane triterpenic saponin compound and its application in the treatment of cardiovascular disease |
| 08/18/2004 | CN1162184C Methods and compositions for specific coagulation of vasculature |
| 08/18/2004 | CN1162181C Methods and composition for treatment of immunologically-mediated diseases using cow mycobacterium |
| 08/18/2004 | CN1162178C Hemorrhoids capsule and its preparing process |
| 08/18/2004 | CN1162173C Blood pressure reducing plaster |
| 08/18/2004 | CN1162158C Slow realease breviscapine formulation having function of promoting blood circulation and removing blood stasis |
| 08/18/2004 | CN1162150C Theopolyphenol composition for injection and its preparing process |
| 08/18/2004 | CN1162149C Medicinal compositions for preventing or treating viral myocarditis |
| 08/17/2004 | US6777577 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis |
| 08/17/2004 | US6777557 Method and composition for rejuvenating cells, tissues organs, hair and nails |
| 08/17/2004 | US6777544 Polyamide nucleic acid derivatives and agents and processes for preparing them |
| 08/17/2004 | US6777443 For therapy of cardiovascular disorders in mammals; for inhibiting both angiotensin converting enzyme and neutral endopeptidase in mammals |
| 08/17/2004 | US6777442 Diphenyl derivatives |
| 08/17/2004 | US6777437 Antidepressants, anxiolytic agents. sexual disorders |
| 08/17/2004 | US6777426 Imidazole and imidazoline derivatives and uses thereof |
| 08/17/2004 | US6777419 Pyrazolo [4,3-d]pyrimidines |
| 08/17/2004 | US6777416 Isoxazolo pyrimidinones and the use thereof |
| 08/17/2004 | US6777414 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same |
| 08/17/2004 | US6777413 For therapy and prophylaxis of conditions in mammals characterized by undesired thrombosis |
| 08/17/2004 | US6777409 For therapy of inflammation |
| 08/17/2004 | US6777408 Pyrido-thieno-diazepines method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 08/17/2004 | US6777403 Method and structure for inhibiting activity of serine elastases |
| 08/17/2004 | US6776796 Antiinflammatory drug and delivery device |
| 08/17/2004 | CA2292921C Aryl carboxylic acid and tetrazole derivatives |
| 08/17/2004 | CA2212010C Extracts of shark cartilage, process of production and uses thereof |
| 08/14/2004 | CA2457465A1 Method for reducing the glycemic index of food |
| 08/12/2004 | WO2004067558A1 Means for regulating the expression of human isoforms of ant |
| 08/12/2004 | WO2004067526A1 CRYSTAL OF (23S)-1α-HYDROXY-27-NOR-25-METHYLENEVITAMIN D3-26,23-LACTONE AND PROCESS FOR PRODUCING THE SAME |
| 08/12/2004 | WO2004067525A1 Vitamin d3 lactone derivative |
| 08/12/2004 | WO2004067506A2 Substituted heterocyclic compounds |
| 08/12/2004 | WO2004067498A2 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 08/12/2004 | WO2004067018A1 Bioavailability enhancing activity of carum carvi extracts and fractions thereof |
| 08/12/2004 | WO2004067008A1 Receptor agonists |
| 08/12/2004 | WO2004067003A1 Medicine for prevention of and treatment for arteriosclerosis and hypertension |
| 08/12/2004 | WO2004066999A1 Compositions containing 2, 2’ -methylenebisbenzimidazole derivatives for treating ischemia-related neuronal damage |
| 08/12/2004 | WO2004066997A2 Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods |
| 08/12/2004 | WO2004066995A1 Method for treating ischemic stroke with melatonin |
| 08/12/2004 | WO2004066993A1 Use of 10-aminoaliphatyl-dibenz[b,f]oxepines for the treatment of degenerative ocular disorders |
| 08/12/2004 | WO2004048368A3 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors |
| 08/12/2004 | WO2004032871A3 Piperazine and piperazinone inhibitors of factor xa |
| 08/12/2004 | WO2004022032A3 Pharmaceutical dosage form comprising a sulfite compound |
| 08/12/2004 | WO2004007498A9 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 08/12/2004 | WO2003106444A8 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 08/12/2004 | WO2003105611A9 Beverages containing plant sterols |
| 08/12/2004 | WO2003032913A3 Methods and compositions for targeting proteins across the blood brain barrier |
| 08/12/2004 | US20040158092 for example, N-(N-acetyl-L-cysteinyl)-S-acetylcysteamine; by protecting the N-acyl-L-cysteine to form an intermediate compound and then coupling intermediate compound with S-acylcysteamine hydrochloride or with thiazolidine |
| 08/12/2004 | US20040158075 Organic acid salt of amlodipine |
| 08/12/2004 | US20040158067 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology |
| 08/12/2004 | US20040157930 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 08/12/2004 | US20040157925 Stable pharmaceutical composition of pravastatin |
| 08/12/2004 | US20040157914 Pyrrolidinone derivatives |
| 08/12/2004 | US20040157909 Modulating protein kinase signal transduction; anticancer agents |
| 08/12/2004 | US20040157903 Antidiabetic agents; synergistic mixture |
| 08/12/2004 | US20040157902 Integrin antagonists |
| 08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
| 08/12/2004 | US20040157890 Dyslipidemia; cardiovascular disorders; antidiabetic agents; eating disorders; antiinflammatory agents; anticholesterol agents |
| 08/12/2004 | US20040157889 Potassium and sodium channel moderators; brain disorders; strokes; multiple sclerosis |
| 08/12/2004 | US20040157888 Method of treating of demyelinating diseases or conditions |
| 08/12/2004 | US20040157886 Brain disorders; central nervous system disorders; viricides |
| 08/12/2004 | US20040157875 1, 6-Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 08/12/2004 | US20040157868 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-beta 1 |
| 08/12/2004 | US20040157866 Amide compounds |